Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive Nutritional Support in Subacute Stroke
NCT04259307Completed
- Sponsor
- Samsung Medical Center
- Start
- Jan 2020
- Primary completion
- Aug 2023
- Modality
- Lipid-based Nanoparticles, Recombinant Proteins and Enzymes, Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of omeprazole + perindopril and Winuf Peri in stroke (2 arms), sponsored by Samsung Medical Center. Primary endpoint: Korean modified Barthel Index at 6 months. Started Jan 2020; status: completed.
02
Drugs
omeprazole + perindoprilWinuf Peri
03
Conditions
stroke
Beyond the preview
Go deeper on NCT04259307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04259307.